Institutional investors hold a majority ownership of GRFS through the 60.02% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2016, these large investors purchased a net $1.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 4.7 Million shares of Grifols SA
PICTET ASSET MANAGEMENT SA Bought 4.0 Million shares of Grifols SA
CREDIT SUISSE SECURITIES (USA) L... Bought 3.8 Million shares of Grifols SA